SARM1 activation triggers axon degeneration locally via NAD + destruction
In research communities, these peptides are often discussed as complementary rather than directly competitive because: GHK-Cu is often chosen for collagen, skin, scar, and cosmetic tissue remodeling goals BPC-157 is often chosen for tendon, ligament, joint, muscle, and deeper recovery goals For that reason, many researchers discussing GHK-Cu vs BPC-157 eventually decide the better question is not which one is better, but which one better matches the tissue target? If you are building a broader research setup, you may also want to browse our research peptide collection for compatible inventory planning
Metal-based systems (MnO, Cu 2 , Fe 3 ) deplete GSH and generate ROS, with imaging potential, though metal toxicity and accumulation are concerns
The peptide has not received approval from Health Canada for therapeutic use in humans
Even if you boil it, maintaining sterility during storage is impossible without proper containers and technique
That decision shapes the compounded GLP-1 market for hospitals, clinics, and telehealth obesity programs that have been buying through outsourcing facilities
